We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$97.6B
AUM Growth
+$13.8B
Cap. Flow
+$6.88B
Cap. Flow %
7.05%
Top 10 Hldgs %
24.85%
Holding
8,027
New
582
Increased
3,285
Reduced
3,349
Closed
442

Sector Composition

Rank Sector Weight
1 Healthcare 5.21%
2 Financials 5.16%
3 Technology 4.66%
4 Consumer Discretionary 3.61%
5 Energy 3.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGTX icon
7301
TG Therapeutics
TGTX
$7.96B
$1K ﹤0.01%
345
-236
-41% -$953
TMQ
7302
CALL
Trilogy Metals
TMQ
$541M
$1K ﹤0.01%
752
UEC icon
7303
CALL
Uranium Energy
UEC
$4.75B
$1K ﹤0.01%
300
BSIN
7304
CALL
Big Sky Industrial
BSIN
$59.6M
$1K ﹤0.01%
5
-3
-38% -$552
USL icon
7305
United States 12 Month Oil Fund,
USL
$45.1M
$1K ﹤0.01%
24
+12
+100% +$509
VCYT icon
7306
Veracyte
VCYT
$3.7B
$1K ﹤0.01%
+80
New +$1.04K
TRAW icon
7307
Traws Pharma
TRAW
$6.85M
0
ALIM
7308
DELISTED
Alimera Sciences
ALIM
$1K ﹤0.01%
25
-17
-40% -$693
BIOL
7309
DELISTED
Biolase, Inc.
BIOL
0
NM
7310
DELISTED
Navios Maritime Holdings Inc.
NM
$1K ﹤0.01%
+10
New +$808
TGA
7311
DELISTED
Transglobe Energy Corp
TGA
$1K ﹤0.01%
+100
New +$883
HSTO
7312
DELISTED
Histogen Inc. Common Stock
HSTO
$1K ﹤0.01%
1
-1
-50% -$1.6K
PVG
7313
DELISTED
PRETIUM RESOURCES INC.
PVG
$1K ﹤0.01%
100
-538
-84% -$2.51K
CXP
7314
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
$1K ﹤0.01%
+26
New +$602
PFBI
7315
DELISTED
Premier Financial Bancorp
PFBI
$1K ﹤0.01%
+139
New +$1.32K
FPRX
7316
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1K ﹤0.01%
+91
New +$1.13K
WPX
7317
CALL
DELISTED
WPX Energy, Inc.
WPX
$1K ﹤0.01%
33
-66
-67% -$1.32K
AVH
7318
DELISTED
AVIANCA HOLDINGS S.A.
AVH
$1K ﹤0.01%
+92
New +$1.35K
SAUC
7319
DELISTED
Diversified Restaurant Holdings, Inc. Common stock
SAUC
$1K ﹤0.01%
235
-165
-41% -$1.01K
AVEO
7320
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1K ﹤0.01%
131
+79
+152% +$1.58K
MNI
7321
CALL
DELISTED
The McClatchy Company Class A Common Stock
MNI
$1K ﹤0.01%
40
-440
-92% -$13.4K
SDLP
7322
DELISTED
SEADRILL PARTNERS LLC
SDLP
$1K ﹤0.01%
+3
New +$961
GZT
7323
DELISTED
Gazit-globe Ltd
GZT
$1K ﹤0.01%
+100
New +$1.34K
INTX
7324
DELISTED
Intersections, Inc.
INTX
$1K ﹤0.01%
210
+116
+123% +$965
CMA.WS
7325
DELISTED
Comerica Incorporated Ws
CMA.WS
$1K ﹤0.01%
+75
New +$1.25K

Similar funds

Barclays's Q4 2013 Portfolio in Review

As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Barclays deployed $6.88B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.

By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.

  • Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
  • Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
  • Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
  • Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
  • Barclays opened 582 new positions and closed 442 in Q4 2013.
  • Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.

Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.